Biomarkers in Vestibular Schwannoma–Associated Hearing Loss

Biomarkers in Vestibular Schwannoma–Associated Hearing Loss

Vestibular schwannomas (VSs) are benign tumors composed of differentiated neoplastic Schwann cells. They can be classified into two groups: sporadic VS and those associated with neurofibromatosis type 2 (NF2). VSs usually grow slowly, initially causing unilateral sensorineural hearing loss (HL) and...

Full description

Bibliographic Details
Main Authors: Luis Lassaletta, Miryam Calvino, Jose Manuel Morales-Puebla, Pablo Lapunzina, Lourdes Rodriguez-de la Rosa, Isabel Varela-Nieto, Victor Martinez-Glez
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Neurology
Subjects:
vestibular schwannoma
neurofibromatosis type 2
biomarkers
hearing loss
perilymph
chemokine
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00978/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.00978/full

Similar Items